Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-06-05
1997-10-28
Kight, John
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
206569, 530300, 530324, 530325, 530326, A61K 5100, A61M 3614
Patent
active
056815417
ABSTRACT:
The invention relates to radiolabeled imaging of a mammalian body. The invention in particular provides for reagents labeled with technetium-99m for such imaging. The invention provides peptides which bind technetium-99m and which can be targeted to specific sites within a mammalian body.
REFERENCES:
patent: 5449761 (1995-09-01), Belinka, Jr. et al.
patent: 5506208 (1996-04-01), Eyal et al.
patent: 5508020 (1996-04-01), Dean et al.
Pearson et al(1996), J. Med. Chem. , vol. 39, No. 7, pp. 1372-1382, "Thrombus Imaging Using Technetium -99m Labeled High Potency GPII10/IVa Receptor Antagonists. Chemistry and Initial Biological Studies".
Diatide, Inc.
Jones Dameron L.
Kight John
LandOfFree
Technetium-99m labeled radiopharmaceutical kit for imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium-99m labeled radiopharmaceutical kit for imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium-99m labeled radiopharmaceutical kit for imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1024058